237 related articles for article (PubMed ID: 8515117)
1. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis.
Hackett SP; Stevens DL
J Infect Dis; 1993 Jul; 168(1):232-5. PubMed ID: 8515117
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide.
Müller-Alouf H; Alouf JE; Gerlach D; Ozegowski JH; Fitting C; Cavaillon JM
Infect Immun; 1994 Nov; 62(11):4915-21. PubMed ID: 7927772
[TBL] [Abstract][Full Text] [Related]
3. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.
Ikejima T; Okusawa S; van der Meer JW; Dinarello CA
J Infect Dis; 1988 Nov; 158(5):1017-25. PubMed ID: 3263446
[TBL] [Abstract][Full Text] [Related]
4. Cytolysins augment superantigen penetration of stratified mucosa.
Brosnahan AJ; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
J Immunol; 2009 Feb; 182(4):2364-73. PubMed ID: 19201891
[TBL] [Abstract][Full Text] [Related]
5. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
Norrby-Teglund A; Nepom GT; Kotb M
Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
7. Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O.
Hackett SP; Stevens DL
J Infect Dis; 1992 May; 165(5):879-85. PubMed ID: 1569337
[TBL] [Abstract][Full Text] [Related]
8. Molecular structure of staphylococcus and streptococcus superantigens.
Schlievert PM; Bohach GA; Ohlendorf DH; Stauffacher CV; Leung DY; Murray DL; Prasad GS; Earhart CA; Jablonski LM; Hoffmann ML; Chi YI
J Clin Immunol; 1995 Nov; 15(6 Suppl):4S-10S. PubMed ID: 8613491
[TBL] [Abstract][Full Text] [Related]
9. Superantigens and streptococcal toxic shock syndrome.
Proft T; Sriskandan S; Yang L; Fraser JD
Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
[TBL] [Abstract][Full Text] [Related]
10. Synergic activities of streptococcal pyrogenic exotoxin A and lipoteichoic acid in cytokine induction.
Cusumano V; Fera MT; Carbone M; Anzani Ciliberti F; Bellantoni A; Cusumano V
New Microbiol; 2000 Jan; 23(1):37-45. PubMed ID: 10946404
[TBL] [Abstract][Full Text] [Related]
11. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.
Schlievert PM; Jablonski LM; Roggiani M; Sadler I; Callantine S; Mitchell DT; Ohlendorf DH; Bohach GA
Infect Immun; 2000 Jun; 68(6):3630-4. PubMed ID: 10816521
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor production by human T-cells stimulated with bacterial superantigens.
Imanishi K; Inada K; Akatsuka H; Gu Y; Igarashi H; Uchiyama T
Int J Immunopharmacol; 1995 Oct; 17(10):841-8. PubMed ID: 8707449
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
14. The role of lipopolysaccharide, pro-inflammatory cytokines and bacterial superantigens in the transcriptional regulation of lymphotoxin alpha and beta in mouse splenocytes.
Zinetti M; Agyekum S; Evans T; Polak J; Cohen J
Cytokine; 1998 Dec; 10(12):940-7. PubMed ID: 10049517
[TBL] [Abstract][Full Text] [Related]
15. Superantigens: microbial agents that corrupt immunity.
Llewelyn M; Cohen J
Lancet Infect Dis; 2002 Mar; 2(3):156-62. PubMed ID: 11944185
[TBL] [Abstract][Full Text] [Related]
16. Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor.
Fast DJ; Schlievert PM; Nelson RD
J Immunol; 1988 Feb; 140(3):949-53. PubMed ID: 3339245
[TBL] [Abstract][Full Text] [Related]
17. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes.
Hashimoto K; Shigeta S; Baba M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434
[TBL] [Abstract][Full Text] [Related]
18. Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1.
Scholl PR; Trede N; Chatila TA; Geha RS
J Immunol; 1992 Apr; 148(7):2237-41. PubMed ID: 1545128
[TBL] [Abstract][Full Text] [Related]
19. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
Smith RJ; Schlievert PM; Himelright IM; Baddour LM
Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
[TBL] [Abstract][Full Text] [Related]
20. A model of human whole blood lymphokine release for in vitro and ex vivo use.
Hermann C; von Aulock S; Graf K; Hartung T
J Immunol Methods; 2003 Apr; 275(1-2):69-79. PubMed ID: 12667671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
